Sweden's Medivir to sell generics unit; PharMerica adopts poison pill after Omnicare offer;

@FiercePharma: Merck's discount offer to NICE wins OK for anti-TNF drug Simponi. Piece | Follow @FiercePharma

> Sweden's Medivir agreed to sell a generics subsidiary BMM Pharma, acquired in its BioPhausia buyout earlier this year, to Bluefish Pharmaceuticals for 38 million krona in cash and inventory, or about $9 million. Medivir release

> PharMerica adopted a poison pill to ward off hostile takeovers after receiving a $441 million bid from larger rival Omnicare ($OCR) earlier this week. Item

> AstraZeneca ($AZN) bought more than 1 million shares for 2826 pence per share as part of its ongoing buyback program. News

> Hi-Tech Pharmacal acquired marketing rights to an ANDA from KVK-Tech for an allergy drug to be marketed under the Lodrane brand name. Hi-Tech release

> UBS cut its target price for Hikma to 850 pence after first half earnings failed to live up to forecasts. Article

Biotech News

@FierceBiotech: Report: Samsung to test genomic analysis service. Item | Follow @FierceBiotech

@JohnCFierce: FDA approves Firazyr (Shire) for HAE. News | Follow @JohnCFierce

@RyanMFierce: Furiex Pharmaceuticals snags $15M loan to advance pipeline, including antibiotic, IBC drug and statin Article | Follow @RyanMFierce

@MaureenFierce: CDC: Teen HPV vaccination rates lagging. Article | Follow @MaureenFierce

> Study: Cancer trial participation less than 1%. Report

> J&J's XR pain drug gets FDA nod. Piece

> Gene therapy breaks 'bubble boy disease.' Article

> Medivir deals generics biz amid HepC drug trials. More

And Finally... The cost of treating obesity and related diseases is expected to add 2% to healthcare bills in the U.S. and U.K. by 2030. Report

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.